These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2654522)
1. Hetrazepines as antagonists of platelet activating factor. Weber KH; Heuer HO Med Res Rev; 1989; 9(2):181-218. PubMed ID: 2654522 [No Abstract] [Full Text] [Related]
2. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series. Weber KH; Heuer H Int Arch Allergy Appl Immunol; 1989; 88(1-2):82-7. PubMed ID: 2540098 [TBL] [Abstract][Full Text] [Related]
4. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017 [TBL] [Abstract][Full Text] [Related]
6. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists. Casals-Stenzel J; Heuer HO Methods Enzymol; 1990; 187():455-65. PubMed ID: 2233357 [No Abstract] [Full Text] [Related]
15. The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). Griffin KJ; Levy JV Thromb Res; 1988 Jul; 51(2):219-23. PubMed ID: 3187959 [No Abstract] [Full Text] [Related]
16. New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists. Braquet P; Esanu A Agents Actions; 1991 Jan; 32(1-2):34-6. PubMed ID: 2058466 [No Abstract] [Full Text] [Related]
17. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption. Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640 [No Abstract] [Full Text] [Related]
18. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists. Heuer HO Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies on triazolothienodiazepine derivatives as platelet-activating factor antagonists. Miyazawa S; Okano K; Shimomura N; Clark RS; Kawahara T; Asano O; Yoshimura H; Miyamoto M; Sakuma Y; Muramoto K Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3215-20. PubMed ID: 1814614 [TBL] [Abstract][Full Text] [Related]
20. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine]. Kulikov VI; Muzia GI Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]